Ocular motor score a novel clinical approach to evaluating ocular motor function in children
Article first published online: 6 JUN 2012
DOI: 10.1111/j.1755-3768.2012.02468.x
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation
Issue

Acta Ophthalmologica
Early View (Online Version of Record published before inclusion in an issue)
Additional Information
How to Cite
Olsson, M., Fahnehjelm, K. T., Rydberg, A. and Ygge, J. (2012), Ocular motor score a novel clinical approach to evaluating ocular motor function in children. Acta Ophthalmologica. doi: 10.1111/j.1755-3768.2012.02468.x
Publication History
- Article first published online: 6 JUN 2012
- Received on July 1st, 2011 Accepted on April 4th, 2012.
- Abstract
- Article
- References
- Cited By
Keywords:
- Ocular motor function;
- ocular motor score;
- reference values
Abstract.
Purpose: Ocular motility disturbances are common in a number of neuropaediatric and neurometabolic disorders. Assessment of ocular motor function can be a source of information for diagnosis and follow-up of these patients.
Aim: To evaluate a new clinical ocular motor function test: ocular motor score (OMS) and provide reference values in children and young adults without known ocular or neurological disorders.
Material and Methods: A total of 233 children and young adults, 103 males and 130 females between the ages of 6 months and 19 years, were assessed according to a specific OMS protocol. They were divided into four different age groups: 0.5–3, 4–6, 7–10 and 11–19 years. The OMS protocol consists of 15 different subtests evaluating ocular motor function, and a total score of minimum 0 up to max 15 can be obtained: the minimum score, 0, is considered normal while 1 represents an abnormal function.
Results: The median OMS in the whole reference group was 0.3 (range 0–4.8). The median OMS in the different age groups, starting with the youngest, was: 0.9 (range 0.3–4.8), 0.3 (range 0–3.4), 0.3 (range 0–2.3) and 0 (range 0–3.5), respectively. The youngest subjects, aged 0.5–3, showed a significantly higher total OMS compared with the other age groups (p < 0.001).
Conclusion: This study provides reference values for the OMS test in a population aged 0.5–19 years. The test may be valuable as a screening tool for identification and follow-up of ocular motor dysfunction in children and young adults.

1755-3768/asset/olbannercenter.gif?v=1&s=baf172706d8b0315485b0acf45bb6cfebe7a6ecc)